All In Biotech

Drug Trial Radar · NCT07008976

Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer

A Randomized, Open-label, Parallel-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in Patients With HER2-positive Advanced Breast Cancer

Last checked: Nov 19, 2026Latest source record: Aug 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 246 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

246

Planned (sponsor's estimate)

Start

Jul 7, 2025

Primary completion

Mar 2028

Study completion Dec 2028

Sponsor

Sponsor type
Industry
First posted
Jun 6, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study adopted a randomized, open-label, positive drug-controlled, multi-center trial design. The primary endpoint was PFS evaluated by the Independent Review Committee (IRC). Eligible subjects were randomly assigned in a 1:1 ratio to receive either TQB2102 for injection or trastuzumab emtansine for injection.

Conditions

  • Metastatic Breast Cancer

Interventions

  • TQB2102 InjectionDrug

    TQB2102 Injection is a Human Epidermal Growth Factor Receptor 2 (HER2) bispecific antibody-drug conjugate.

  • Trastuzumab Emtansine for InjectionDrug

    Trastuzumab Emtansine for Injection is HER2-targeting antibody-drug conjugate (ADC).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Progression-Free Survival (PFS) evaluated by Independent Review Committee (IRC)Time frame: Up 30 months

Locations

31 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Anhui Medical University

    Bengbu, Anhui, China · Not yet recruiting

  • Anhui Provincial Cancer Hospital

    Hefei, Anhui, China · Recruiting

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China · Not yet recruiting

  • Peking University First Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Beijing Shunyi Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Fujian Cancer Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • The First Hospital Of Lanzhou University

    Lanzhou, Gansu, China · Not yet recruiting

  • Jiangmen Central Hospital

    Jiangmen, Guangdong, China · Not yet recruiting

  • Affiliated Cancer Hospital Of Guangxi Medical University

    Nanning, Guangxi, China · Not yet recruiting

  • Cancer Hospital Of Guizhou Medical University

    Guiyang, Guizhou, China · Not yet recruiting

  • Hainan General Hospital

    Haikou, Hainan, China · Not yet recruiting

  • The Fourth Hospital Of Hebei Medical University

    Shijiazhuang, Hebei, China · Not yet recruiting

  • Affiliated Cancer Hospital Of Harbin Medical University

    Harbin, Heilongjiang, China · Not yet recruiting

  • Jiamusi Tuberculosis Hospital (Jiamusi Tumor Hospital)

    Jiamusi, Heilongjiang, China · Not yet recruiting

  • Anyang Cancer Hospital

    Anyang, Henan, China · Not yet recruiting

  • The First Affiliated Hospital Of Henan University Of Science & Technology

    Luoyang, Henan, China · Not yet recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Not yet recruiting

  • Chifeng Municipal Hospital

    Chifeng, Inner Mongolia, China · Not yet recruiting

  • Jiangxi Cancer Hospital

    Nanchang, Jiangxi, China · Not yet recruiting

  • Jilin Cancer Hospital

    Changchun, Jilin, China · Not yet recruiting

  • The First Hospital of Jilin University

    Changchun, Jilin, China · Not yet recruiting

  • The Second Hospital Of Dalian Medical University

    Dalian, Liaoning, China · Not yet recruiting

  • Liaoning Cancer Hospital & Institute

    Shenyang, Liaoning, China · Not yet recruiting

  • Affiliated Hospital Of Jining Medical University

    Jining, Shandong, China · Not yet recruiting

  • Linyi Cancer Hospital

    Linyi, Shandong, China · Not yet recruiting

  • Fudan University Shanghai Cancer Center

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Dazhopu Central Hospital

    Dazhou, Sichuan, China · Not yet recruiting

  • Affiliated Hospital of North Sichuan Medical College

    Nanchong, Sichuan, China · Not yet recruiting

  • Tianjin Medical University Cancer Institute & Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Hangzhou Cancer Hospital

    Hangzhou, Zhejiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.